Endocrine Therapy in Breast Cancer: Improving Clinical Benefits
Most breast cancers express the estrogen and/or progesterone hormone receptors, which fuel tumor growth upon engagement with their respective...
Tag: SABCS
Home »
Most breast cancers express the estrogen and/or progesterone hormone receptors, which fuel tumor growth upon engagement with their respective...
About 80 percent of breast cancers express the estrogen receptor (ER). In ER-positive tumors, estrogen is the main driver...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
As recently as 10 years ago, the words “machine learning” evoked thoughts of sentient robots and fears of the...
Surrounding a tumor is a vast network of blood vessels, immune cells, proteins, and even bacteria, all of which...
Triple-negative breast cancer (TNBC) is aggressive, with high risk of metastasis and recurrence, and is challenging to treat due to a lack of effective targeted therapies. However, a higher...
Thirty years ago, Mary-Claire King, PhD, FAACR, and colleagues were the first to demonstrate that breast cancer could be genetically inherited....
Several options are available for the treatment of breast cancer, including local therapies such as surgery and radiation therapy,...
As we approach the end of the year that was consumed by the pandemic, more than 68 million people...
Editor’s note: When the San Antonio Breast Cancer Symposium (SABCS) kicks off next week, researchers will present the results...